| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/JCEM.84.11.6236 |
| P698 | PubMed publication ID | 10566687 |
| P2093 | author name string | Jüppner H | |
| Salusky IB | |||
| Goodman WG | |||
| Gao P | |||
| John MR | |||
| Cantor TL | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4287-4290 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure | |
| P478 | volume | 84 |
| Q36087092 | A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism |
| Q80606749 | Association of increased active PTH(1-84) fraction with decreased GFR and serum Ca in predialysis CRF patients: modulation by serum 25-OH-D |
| Q44780904 | Bone histology in steroid-treated children with non-azotemic nephrotic syndrome |
| Q34402661 | Chronic kidney disease: mineral and bone disorder in children |
| Q36985741 | Cinacalcet reduces the set point of the PTH-calcium curve |
| Q36523935 | Circulating PTH molecular forms: what we know and what we don't |
| Q37201624 | Defining vitamin D deficiency, using surrogate markers |
| Q38023142 | Diagnosis and management of parathyroid cancer. |
| Q81217821 | Differences between "intact" PTH and 1-84 PTH assays in chronic renal failure and dialysis |
| Q37912038 | Diseases of the parathyroid gland in chronic kidney disease. |
| Q79537591 | Effect of haemodialysis on markers of bone turnover in children |
| Q38970634 | How the reference values for serum parathyroid hormone concentration are (or should be) established? |
| Q51799713 | Hypoparathyroidism. |
| Q33899996 | Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study |
| Q35563713 | Intraoperative Testing for Parathyroid Hormone: A Comprehensive Review of the Use of the Assay and the Relevant Literature |
| Q48514301 | Intraoperative parathyroid hormone levels measured by intact and whole parathyroid hormone assays in patients with Graves' disease |
| Q37193525 | Lessons from second- and third-generation parathyroid hormone assays in primary hyperparathyroidism |
| Q44590717 | Low Estrogen and High Parathyroid Hormone-Related Peptide Levels Contribute to Accelerated Bone Resorption and Bone Loss in Lactating Mice |
| Q37938689 | Mineral and bone disorders in children with chronic kidney disease |
| Q80152901 | New PTH assays and renal osteodystrophy |
| Q35553304 | New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure |
| Q47423087 | Parathyroid hormone and its fragments in children with chronic renal failure |
| Q37610750 | Parathyroid hormone measurement in CKD. |
| Q33212214 | Predictive value of intact parathyroid hormone measurement during surgery for renal hyperparathyroidism |
| Q47892535 | Predictors of intra-operative parathyroid hormone decline in subjects operated for primary hyperparathyroidism by minimally invasive parathyroidectomy |
| Q42701367 | Rapid intraoperative parathyroid hormone assay in the surgical management of hyperparathyroidism |
| Q38762250 | Redefining vitamin D deficiency: Reply to comments |
| Q84179469 | Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism |
| Q36606963 | Regulation of parathyroid function in chronic kidney disease (CKD). |
| Q36298407 | Report of an NIH task force on research priorities in chronic kidney disease in children |
| Q37207904 | Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols |
| Q35573599 | Reversed whole PTH/intact PTH ratio as an indicator of marked parathyroid enlargement: five case studies and a literature review |
| Q49082608 | Role of cyclase activating parathyroid hormone (1-84 PTH) measurements during parathyroid surgery: potential improvement of intraoperative PTH assay. |
| Q35568749 | Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment |
| Q51240117 | Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism. |
| Q44637520 | Sevelamer hydrochloride: an effective phosphate binder in dialyzed children |
| Q45025729 | Significance of Bio-intact PTH(1-84) assay in hemodialysis patients |
| Q37319131 | Technical approach to iliac crest biopsy |
| Q33984825 | The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84) |
| Q36638034 | The kidney and bone metabolism: Nephrologists' point of view. |
| Q36534774 | The need for reliable serum parathyroid hormone measurements |
| Q36523930 | The parathyroid polyhormone hypothesis revisited |
| Q35569258 | Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting. |
| Q81024586 | Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects |
| Q83781585 | [Biology of primary hyperparathyroidism: selective venous sampling] |
| Q79260193 | “Incipient” Primary Hyperparathyroidism: A “Forme Fruste” of an Old Disease |
Search more.